JSTOR

Infection Control and Hospital Epidemiology Publication Info

Article DOI: 10.1086/502184
Stable URL: http://www.jstor.org/stable/10.1086/502184
Contamination of Trypan Blue With Burkholderia cepacia in a Cornea Bank • 
Pascal C. Morel , MD, Nora Roubi , PhD, Daniel R. Talon , PhD and Xavier Bertrand , PhD
Infection Control and Hospital Epidemiology , Vol. 24, No. 3 (March 2003), pp. 198-201
Article DOI: 10.1086/502184
Article Stable URL: http://www.jstor.org/stable/10.1086/502184
Original Articles

Contamination of Trypan Blue With Burkholderia cepacia in a Cornea Bank

Formats Available in JSTOR: PDF

Abstract(back to top)

OBJECTIVE. To describe Burkholderia cepacia contamination of a cornea bank and the measures taken to identify and eliminate the source of infection.

METHODS. Cultures were performed to assess the extent and source of contamination, and pulsed‐field gel electrophoresis was used for molecular typing.

RESULTS. Routine surveillance cultures identified 5 contaminated corneas during a 10‐day period. Additional cultures showed that 28 of 88 samples were positive for this organism. Environmental investigation showed that an open bottle of trypan blue used to assess corneal morphology was contaminated with the epidemic strain.

CONCLUSION. Trypan blue played a major role in this contamination of corneas. This episode shows that microbial contamination can affect transplanted corneas despite ongoing culture surveillance and suggests that new methods may be needed to avoid this risk.

Bibliographic Information(back to top)

  • Contamination of Trypan Blue With Burkholderia cepacia in a Cornea Bank
  • Pascal C. Morel , MD, Nora Roubi , PhD, Daniel R. Talon , PhD and Xavier Bertrand , PhD
  • Infection Control and Hospital Epidemiology
  • Vol. 24, No. 3 (March 2003) (pp. 198-201)

Author Information(back to top)

Pascal C. Morel , MD; Nora Roubi , PhD; Daniel R. Talon , PhD; Xavier Bertrand , PhD

Notes and References(back to top)

This item contains 1 note(s).

Notes

Drs. Morel and Roubi are from Unité de Thérapie Cellulaire et Génique, Etablissement Fran�ais du Sang, Besan�on, France. Drs. Talon and Bertrand are from Service d’Hygi�ne hospitali�re et d’Epidémiologie moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besan�on, France. Address reprint requests to Xavier Bertrand, MD, Service d’Hygi�ne hospitali�re et d’Epidémiologie moléculaire, Centre Hospitalier Universitaire Jean Minjoz, 25030 Besan�on, France.

Items Citing this Item (back to top)

2 item(s) in JSTOR cite this item

© 2003 by The Society for Healthcare Epidemiology of America. All rights reserved.